AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Observational Study on the Treatment of Trigeminal Neuralgia by Radiosurgery

Recruitingn/aAges 18 Years - anyAllCentre Hospitalier Princesse Grace
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the outcome of patient treated by radiosurgery on LINAC with high dose rate for classical trigeminal neuralgia

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Classical trigeminal neuralgia according the International Classification of Headache Disorders * Trigeminal neuralgia resistant to the maximum tolerated medical therapy, with pain intensity according to the Barrow Neurological Institute (BNI) score IV or V. * Patients aged \> 18 Exclusion Criteria: * Patients suffering from secondary Trigeminal neuralgia (tumour in the cerebellopontine angle, arteriovenous malformation or multiple sclerosis) * Previous history of radiosurgery procedure
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Centre Hospitalier Princesse Grace
Monaco, Monaco
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy